Open Orphan (@OpenOrphan) header
Open Orphan (@OpenOrphan) profile picture

We have changed our name to hVIVO plc, ticker: HVO. Follow @hVIVO_UK to keep up to date.

London, United Kingdom
Joined December 2017
Today we officially change our name to hVIVO on @LSEGplc AIM and @euronext_ie📣 Find all the latest news & investor information here: hvivo.com 👉Don’t forget to start following @hVIVO_UK. 📈 Our new ticker is #HVO
4
14
Further to our recent announcement, #ORPH's name change to hVIVO plc has now been completed and is expected to take effect on @LSEGplc AIM & @euronext_ie from 8.00 am tomorrow. Learn more: londonstockexchange.com/news… Follow us on @hVIVO_UK to keep up to date! #HVO
3
15
Last week we announced our upcoming Capital Markets Day on Wednesday 2 November 2022 at 9.30 am - 12.00 pm (GMT). Register below if you would like to attend virtually ⏬ stream.brrmedia.co.uk/broadc… #HVO #CapitalMarketsDay #ORPH
1
9
We're holding a Capital Markets Day on 2 Nov 2022. 🧑Chaired by our #CEO 🔬 Insights into the business 📈 Human challenge trials & the growing market 🗣️ Guest speakers, including @p_openshaw ❓ Q&A with #ORPH management londonstockexchange.com/news… #HVO
4
11
Stephen Pinkerton has been appointed as #CFO and Exec Director of #ORPH. Wealth of experience: ☑️ 25 years in Senior Financial Roles ☑️ Served as Commercial Financial Director @hVIVO_UK since 2017 driving initiatives to improve profitability londonstockexchange.com/news… #HVO
3
16
As part of our company name change to hVIVO, our social media will be moving across to the @hVIVO_UK socials. Make sure you follow #hVIVO to keep up to date with company newsflow. See you there 👋! The name change countdown is on...⏲️ #HVO
7
1
23
We announced that we will be changing our name from Open Orphan to #hVIVO on 26 Oct 2022. Our ticker will be changing from #ORPH to #HVO. Watch below to see reasons why we decided to make this strategic business decision... Follow @hVIVO_UK to keep up to date!
1
6
2
29
Our new investors section will be going live alongside our name change launch, which is expected to take place on 26 October 2022. Stay tuned...👀 and don't forget to follow @hVIVO_UK for updates #WatchThisSpace #StayTuned #Rebrand #HVO #hVIVO #ORPH
Positive #data from a peer-reviewed study evaluating the in vitro efficacy of FLU-v, @ImutexLtd broad spectrum #influenza #vaccine candidate, has been published in the scientific journal @Vaccines. Learn more: londonstockexchange.com/news… #HVO #Imutex #Flu #ORPH
1
13
3
26
This morning our #CEO purchased 510,204 #ORPH shares at 9.8 pence per share. "…The purchase of shares in the Company demonstrates both my commitment and my confidence in our long-term growth strategy…” Yamin 'Mo' Khan londonstockexchange.com/news…
Some of our @hVIVO_UK team will be attending and presenting at the #OptionsXI for the Control of #Influenza conference & the 12th International #RSV Symposium in Belfast this week Learn more: londonstockexchange.com/news… #infectiousdisease #research #clinicaltrials
4
16
Here @proactive_UK's @TheChrisRhodes & analyst Daniel Appiah discuss #ORPH's H1 results. They highlight increasing demand for challenge trials & growing contract order book, which stands at over £80mln — almost 3X the value during the same period FY2021 youtube.com/watch?v=t8vLL10m…
7
17
Our interims presentation deck used during the @investormeetco presentation on Thursday 8 September is now available to download ⬇️. Click below👇 to view & download PDF: openorphan.com/investors/rep… #HVO #ORPH #Interim #Results
1
4
1
17
If you missed last weeks @investormeetco presentation featuring our #CEO & #CFO, you can watch it here: youtube.com/watch?v=GRsTsN4E… Highlights: ☑️ Operational & Financial Overview H1 2022 ☑️ Name change to @hVIVO_UK & ticker: HVO ☑️ H2 plans & outlook #HVO
1
1
14